Tag: Takedas
FiercePharmaAsia—China’s price-slashing round; Takeda’s Japan cuts; Sinopharm’s COVID-19 vaccine price
Multinational pharmas, including Eli Lilly, Pfizer, Merck & Co. and AstraZeneca, lost to local generic makers in China's third round of bulk procurement bidding...
